Overview

Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

This is a trial of Ateronon in Patients with Coronary Disease to Evaluate its Effectiveness in Assessing the Risk Factors of Atherosclerosis.

Phase:

Phase 3

Details

Lead Sponsor:

Omicron Pharmaceuticals